U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acute monocytic leukemia

MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
Synonyms: Acute Monoblastic Leukemia; Acute Monoblastic Leukemias; Acute Monocytic Leukemia; Acute Monocytic Leukemias; Leukemia, Acute Monocytic; Leukemia, Monoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute, M5; Leukemia, Myeloid, Schilling Type; Leukemia, Myeloid, Schilling-Type; Leukemia, Schilling-Type Myeloid; Leukemias, Acute Monoblastic; Leukemias, Acute Monocytic; Monoblastic Leukemia, Acute; Monoblastic Leukemias, Acute; Monocytic Leukemia, Acute; Monocytic Leukemias, Acute; Myeloid Leukemia, Acute, M5; Myeloid Leukemia, Schilling Type; Myeloid Leukemia, Schilling-Type; Schilling-Type Myeloid Leukemia
SNOMED CT: Acute monocytic leukemia (413441006); Acute monocytic leukemia, morphology (22331004); Acute monocytic leukemia (22331004); Acute monoblastic leukemia (22331004); FAB M5 (22331004); FAB M5B (22331004); Acute monoblastic leukemia (413441006)
Modes of inheritance:
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
HPO: HP:0004845
Monarch Initiative: MONDO:0007896
OMIM®: 151380
Orphanet: ORPHA514

Definition

The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation. [from HPO]

Clinical features

From HPO
Acute monocytic leukemia
MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcute monocytic leukemia

Conditions with this feature

Acute monocytic leukemia
MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation.
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
MedGen UID:
321945
Concept ID:
C1832388
Disease or Syndrome
RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).
Neutropenia, severe congenital, 1, autosomal dominant
MedGen UID:
348506
Concept ID:
C1859966
Disease or Syndrome
ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%. Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.

Professional guidelines

PubMed

Salillas S, Raaijmakers J, Aarnoutse RE, Svensson EM, Asouit K, van den Hombergh E, Te Brake L, Stemkens R, Wertheim HFL, Hoefsloot W, van Ingen J
Antimicrob Agents Chemother 2024 Mar 6;68(3):e0115723. Epub 2024 Jan 23 doi: 10.1128/aac.01157-23. PMID: 38259101Free PMC Article
Anami Y, Deng M, Gui X, Yamaguchi A, Yamazaki CM, Zhang N, Zhang CC, An Z, Tsuchikama K
Mol Cancer Ther 2020 Nov;19(11):2330-2339. Epub 2020 Sep 2 doi: 10.1158/1535-7163.MCT-20-0407. PMID: 32879051Free PMC Article
McKenna RW, Bloomfield CD, Dick F, Nesbit ME, Brunning RD
Blood 1975 Oct;46(4):481-94. PMID: 169929

Recent clinical studies

Etiology

Ito N, Yamada M, Morishita K, Nojima S, Motooka K, Sakata N, Asuka T, Otsu R, Takamatsu S, Kamada Y, Mori S, Akita H, Eguchi H, Morii E, Miyoshi E
Glycoconj J 2021 Feb;38(1):45-54. Epub 2021 Feb 1 doi: 10.1007/s10719-020-09970-8. PMID: 33523362
Moore AS, Kearns PR, Knapper S, Pearson AD, Zwaan CM
Leukemia 2013 Jul;27(7):1451-60. Epub 2013 Apr 8 doi: 10.1038/leu.2013.106. PMID: 23563239
Dinulos JG, Hawkins DS, Clark BS, Francis JS
J Pediatr 1997 Aug;131(2):300-3. doi: 10.1016/s0022-3476(97)70170-7. PMID: 9290620
Smith MA, Rubinstein L, Ungerleider RS
Med Pediatr Oncol 1994;23(2):86-98. doi: 10.1002/mpo.2950230205. PMID: 8202047
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C
Br J Haematol 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x. PMID: 188440

Diagnosis

Beatty CJ, Ghareeb ER
N Engl J Med 2021 Aug 5;385(6):e19. doi: 10.1056/NEJMicm2101571. PMID: 34347955
Matarraz S, Almeida J, Flores-Montero J, Lécrevisse Q, Guerri V, López A, Bárrena S, Van Der Velden VHJ, Te Marvelde JG, Van Dongen JJM, Orfao A
Cytometry B Clin Cytom 2017 May;92(3):218-227. Epub 2015 Aug 18 doi: 10.1002/cyto.b.21219. PMID: 26282340
Kysia RF, Brown DF, Nadel ES
J Emerg Med 2004 Nov;27(4):407-10. doi: 10.1016/j.jemermed.2004.08.001. PMID: 15498623
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C
Br J Haematol 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x. PMID: 188440
Weetman RM, Baehner RL
Curr Probl Pediatr 1973 Aug;3(10):1-51. PMID: 4592793

Therapy

Beatty CJ, Ghareeb ER
N Engl J Med 2021 Aug 5;385(6):e19. doi: 10.1056/NEJMicm2101571. PMID: 34347955
Moore AS, Kearns PR, Knapper S, Pearson AD, Zwaan CM
Leukemia 2013 Jul;27(7):1451-60. Epub 2013 Apr 8 doi: 10.1038/leu.2013.106. PMID: 23563239
Ohno S, Yokoo T, Ohta M, Yamamoto M, Danno K, Hamato N, Tomii K, Ohno Y, Kobashi Y
J Am Acad Dermatol 1990 Feb;22(2 Pt 2):374-7. doi: 10.1016/0190-9622(90)70052-j. PMID: 2406302
Arnold AM
Cancer Chemother Pharmacol 1979;3(2):71-80. doi: 10.1007/BF00254976. PMID: 389478
Weetman RM, Baehner RL
Curr Probl Pediatr 1973 Aug;3(10):1-51. PMID: 4592793

Prognosis

Terao T, Matsue K
N Engl J Med 2021 Feb 18;384(7):650. doi: 10.1056/NEJMicm2026508. PMID: 33596359
Wu J, Xiao Y, Sun J, Sun H, Chen H, Zhu Y, Fu H, Yu C, E W, Lai S, Ma L, Li J, Fei L, Jiang M, Wang J, Ye F, Wang R, Zhou Z, Zhang G, Zhang T, Ding Q, Wang Z, Hao S, Liu L, Zheng W, He J, Huang W, Wang Y, Xie J, Li T, Cheng T, Han X, Huang H, Guo G
J Hematol Oncol 2020 Sep 25;13(1):128. doi: 10.1186/s13045-020-00941-y. PMID: 32977829Free PMC Article
Hoffman LM, Gore L, Maloney KW
J Pediatr Hematol Oncol 2014 Apr;36(3):228-30. doi: 10.1097/MPH.0b013e31828e5077. PMID: 23619108
Miyoshi I, Uemura Y, Sonobe H, Taguchi H
Intern Med 2007;46(1):65-6. Epub 2007 Jan 1 doi: 10.2169/internalmedicine.46.6232. PMID: 17202740
Arnold AM
Cancer Chemother Pharmacol 1979;3(2):71-80. doi: 10.1007/BF00254976. PMID: 389478

Clinical prediction guides

Ren J, Szombath G, Vitale-Cross L, Stroncek DF, Robey PG, Hajdara A, Szalayova I, Mayer B, Martin D, Mezey E, Nemeth K
Int J Mol Sci 2023 Aug 26;24(17) doi: 10.3390/ijms241713258. PMID: 37686058Free PMC Article
Thi Kim Ly B, Chi HT
J BUON 2020 Jan-Feb;25(1):549-553. PMID: 32277682
Lawrence H, Mawdesley AE, Holland JP, Kirby JA, Deehan DJ, Tyson-Capper AJ
Oncotarget 2016 Feb 16;7(7):7578-85. doi: 10.18632/oncotarget.7105. PMID: 26840091Free PMC Article
Arnold AM
Cancer Chemother Pharmacol 1979;3(2):71-80. doi: 10.1007/BF00254976. PMID: 389478
Koziner B, McKenzie S, Straus D, Clarkson B, Good RA, Siegal FP
Blood 1977 Jun;49(6):895-901. PMID: 324537

Recent systematic reviews

Fang JF, Yuan HN, Song YF, Sun PB, Zheng XL, Wang XJ
Chin Med J (Engl) 2017 Jun 20;130(12):1481-1490. doi: 10.4103/0366-6999.207474. PMID: 28584213Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...